Michael S. Magee
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 14
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 4
- Immunology 12
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- Co-authors
- Adam E. Snook (16 shared papers)Scott A. Waldman (15 shared papers)Glen P. Marszalowicz (7 shared papers)Trevor R. Baybutt (3 shared papers)Jieru E. Lin (4 shared papers)Michael Valentino (3 shared papers)Tara S. Abraham (2 shared papers)Terry Hyslop (2 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)PLoS ONE (2 papers)Blood (2 papers)Toxins (1 paper)
- Partner nations
- United StatesFinlandGermany
In The Last Decade
Michael S. Magee
20 papers receiving 699 citations
Peers
Comparison fields: 5 of 77
- Oncology 424
- Immunology 264
- Biotechnology 64
- Gastroenterology 29
- Endocrine and Autonomic Systems 34
Countries citing papers authored by Michael S. Magee
This map shows the geographic impact of Michael S. Magee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Magee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Magee more than expected).
Fields of papers citing papers by Michael S. Magee
This network shows the impact of papers produced by Michael S. Magee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Magee. The network helps show where Michael S. Magee may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Magee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 125 | |
| 2 | 2018 | 115 | |
| 3 | 2012 | 71 | |
| 4 | 2016 | 66 | |
| 5 | Colorectal cancer immunotherapy. | 2013 | 52 |
| 6 | 2014 | 36 | |
| 7 | 2021 | 36 | |
| 8 | 2012 | 35 | |
| 9 | Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer. | 2014 | 35 |
| 10 | 2010 | 27 | |
| 11 | 2017 | 26 | |
| 12 | 2014 | 25 | |
| 13 | 2014 | 21 | |
| 14 | 2011 | 17 | |
| 15 | 2011 | 10 | |
| 16 | 2013 | 8 | |
| 17 | 2023 | 3 | |
| 18 | 2014 | 3 | |
| 19 | 2018 | 2 | |
| 20 | 2014 | 1 |
About Michael S. Magee
Michael S. Magee is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biotechnology, having authored 21 papers that have together received 714 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Research and Treatments (3 papers), Virus-based gene therapy research (3 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Oncology (424 citations), Immunology (264 citations), Biotechnology (64 citations), Gastroenterology (29 citations) and Endocrine and Autonomic Systems (34 citations). Michael S. Magee has collaborated with scholars based in United States, Finland and Germany. Frequent co-authors include Adam E. Snook, Scott A. Waldman, Glen P. Marszalowicz, Trevor R. Baybutt, Jieru E. Lin, Michael Valentino, Tara S. Abraham, Terry Hyslop, Stephanie Schulz and Gilbert W. Kim. Their work appears in journals such as Journal of Clinical Investigation, Journal for ImmunoTherapy of Cancer, PLoS ONE, Blood and Toxins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.